Cohn-Cedermark G, Rutqvist L E, Andersson R, Breivald M, Ingvar C, Johansson H, Jönsson P E, Krysander L, Lindholm C, Ringborg U
Department of Oncology-Pathology, Radiumhemmet, Karolinska Hospital, Stockholm, Sweden.
Cancer. 2000 Oct 1;89(7):1495-501.
Large, prospective, randomized trials with long term follow-up are required to obtain an unbiased evaluation of the significance of resection margins in patients with cutaneous melanoma.
The Swedish Melanoma Study Group performed a prospective, randomized, multicenter study of patients with primary melanoma located on trunk or extremities and with a tumor thickness > 0.8 mm and </= 2 mm. Patients were allocated randomly to a 2-cm excision margin or a 5-cm excision margin. In total, 989 patients were recruited during the period 1982-1991. The median follow-up was 11 years (range, 7-17 years) for estimation of survival and 8 years (range, 0-17 years) for evaluation of recurrent disease.
The crude rate of local recurrence, defined as a recurrence in the scar or transplant, was < 1% (8 of 989 patients). Twenty percent of the patients (194 of 989 patients) experienced any disease recurrence, and 15% (146 of 989 patients) died of melanoma. There were no statistically significant differences between the two treatment arms. In a multivariate Cox analysis with patients allocated to wide excision as the reference group, the estimated relative hazards for overall survival and recurrence free survival among those allocated to a 2-cm resection margin were 0.96 (95% confidence interval, 0.75-1.24), and 1.02 (95% confidence interval, 0.80-1.30), respectively.
In this long term follow-up study, local recurrences were found to be rare among patients with tumors > 0.8 mm thick and </= 2.0 mm thick. No difference in recurrence rate or survival between the two treatment groups was found. Patients in this category can be treated with a resection margin of 2 cm as safely as with a resection margin of 5 cm.
需要进行大规模、前瞻性、随机且长期随访的试验,以对皮肤黑色素瘤患者手术切缘的意义进行无偏倚评估。
瑞典黑色素瘤研究小组对躯干或四肢原发性黑色素瘤、肿瘤厚度>0.8 mm且≤2 mm的患者进行了一项前瞻性、随机、多中心研究。患者被随机分配至2 cm切缘或5 cm切缘组。1982年至1991年期间共招募了989例患者。评估生存率的中位随访时间为11年(范围7 - 17年),评估疾病复发的中位随访时间为8年(范围0 - 17年)。
局部复发的粗发生率(定义为瘢痕或移植部位复发)<1%(989例患者中有8例)。20%的患者(989例患者中有194例)出现任何疾病复发,15%(989例患者中有146例)死于黑色素瘤。两个治疗组之间无统计学显著差异。在以接受广泛切除的患者为参照组的多变量Cox分析中,分配至2 cm手术切缘组的患者总生存率和无复发生存率的估计相对风险分别为0.96(95%置信区间,0.75 - 1.24)和1.02(95%置信区间,0.80 - 1.30)。
在这项长期随访研究中,发现肿瘤厚度>0.8 mm且≤2.0 mm的患者中局部复发罕见。两个治疗组在复发率或生存率方面未发现差异。此类患者接受2 cm手术切缘治疗与5 cm手术切缘治疗同样安全。